Semaglutide and tirzepatide were associated with better hospitalization and mortality outcomes than sitagliptin in HFpEF and type 2 diabetes.

The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...

Millions of people struggle with lower back pain worldwide. Now, surprising new research from the University of South ...

A 12-month pilot study of Pacira BioScience’s iovera for chronic lower back pain showed it was favorable compared to compared to radiofrequency ablation, according to a Dec. 2 news release.

A 37-year-old woman presents as a new patient. Her past medical history consists of depression, fatigue, anxiety, insomnia ...

Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system ...

Spinal stenosis is a back condition that may cause difficulty walking. Exercises, stretches, and lifestyle changes may improve lower back strength and posture to help manage the condition. Spinal ...

Why Does My Tooth Hurt? Whether it's sharp and sudden or dull and constant, tooth pain is hard to ignore. A toothache or tooth pain is caused when the nerve in the root of a tooth or surrounding a ...

Data sources Medline, Embase, CINAHL via EBSCO, Web of Science, Scopus. Eligibility criteria for selecting studies Studies evaluating the incidence and/or prevalence of LBP in adolescent athletes ...